key: cord-0884555-8rykxpan
authors: Skayem, C.; Hua, C.; Zehou, O.; Jannic, A.; Viarnaud, A.; Wolkenstein, P.; Duong, T.A.
title: Skin cancer and COVID‐19: was the diagnosis safeguarded by teledermatology? a study on 1229 cases
date: 2022-04-26
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.18138
sha: 20c8088d9d1dc5db041ea4a9b0f32db34b77b078
doc_id: 884555
cord_uid: 8rykxpan

nan

Skin cancer cases among teledermatology (TD) total requests, institution requests and non-institution requests during both COVID-19 waves in 2020 vs 2019. non-institutions requests during both waves were also compared with the same period in 2019.

First wave (March and April 2020 vs 2019): The total number of requests was 583 in 2019 vs. 629 in 2020. Skin diagnoses are represented in Fig. 1 . In 'other' diagnoses, 32.1% of these diagnoses (55/171) were COVID-19-related cutaneous lesions, mostly chilblains (70.9%). Regarding SC, the comparison of institution requests and non-institutions requests in 2020 vs 2019 is represented in Fig. 2 .

Second wave (October and November 2020 vs 2019): (Figs 1  and 2) .

The total number of requests was 547 in 2019 vs. 600 in 2020. In 'other diagnoses', 11.4% of these diagnoses (10/87) were COVID-19-related cutaneous lesions.

In total, during the first wave, there was significantly fewer concern in skin cancer and more concern in 'other' skin diagnoses, which included COVID-19-related cutaneous signs. Both institutions and non-institution requests for SC significantly decreased. During the 2nd wave, there was no significant difference in any type of skin diagnosis.

During the first pandemic wave, LTCF physicians seemed more concerned about COVID-19 than other health issues. This is because outbreaks of infection developed rapidly in LTCF 3 and elderly are more vulnerable to infections and at a higher mortality risk. Since confinement was essential for COVID-19 control 1 and public health endorsed social distancing, less patients consulted their general physicians (GPs). Moreover, physicians cancelled consultations to avoid virus transmission.

During the first wave, there was a decrease in overall in-person oncology referrals. 4 Unexpectedly, even though access to TD expertise was possible, there was also a decrease in SC requests. The delay in SC diagnosis was manifested by an increase in Breslow thickness in primary melanomas seen after the first COVID-19 lockdown. 5 Shortly after the first pandemic, all health care professionals were urged to shift their activity to telemedicine, which has become a cornerstone for continuity of care. 6, 7 Consultations were less likely to be cancelled. Moreover, a balance was made between medical attention to COVID patients and regular attention to other patients. Contrary to the persistence of a general decline in skin cancer diagnoses during the second wave, 6, 8, 9 SC diagnosis through TD showed no decrease compared to 2019.

Since TD has already shown efficacy in diagnosis and management of SC, 10, 11 it is important for physicians to scale the use of TD in order to prevent unnecessary in-person visits and help schedule specific appointments for vulnerable patients. Prompting doctors to use TD for SC diagnosis and SC pathway organization would prevent increased morbidity, mortality and health care costs.

None. 

Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?

Dermatological emergency unit, daycare hospital and consultations in time of COVID-19: the impact of teledermatology

Nursing homes or besieged castles: COVID-19 in northern Italy

Impact of the COVID-19 pandemic in cancer diagnosis in the first and second waves in one of the most affected cancer areas in the city of Madrid (Spain)

Delayedmelanoma diagnosis inthe COVID-19era: increased breslow thickness inprimary melanomas seenafterthe COVID-19 lockdown

The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities

Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology

Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis

The unfavorable effects of COVID-19 on Dutch advanced melanoma care

Teledermatology for the diagnosis and management of skin cancer: a systematic review

A process modelling approach to assess the impact of teledermatology deployment onto the skin tumor care pathway